FDA Inspection 1245682 — Sofie Co.

Sofie Co. — FEI 3008297570

The FDA completed an inspection of Sofie Co. on Jul 12, 2024 in Romeoville, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 12, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Romeoville, IL (United States)